Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases

被引:67
作者
Ceuleers, Hannah [1 ]
Van Spaendonk, Hanne [1 ]
Hanning, Nikita [1 ]
Heirbaut, Jelena [1 ]
Lambeir, Anne-Marie [2 ]
Joossens, Jurgen [3 ,4 ]
Augustyns, Koen [3 ,4 ]
De Man, Joris G. [1 ]
De Meester, Ingrid [2 ]
De Winter, Benedicte Y. [1 ]
机构
[1] Univ Antwerp, Div Gastroenterol, Lab Expt Med & Pediat, Univ Pl 1, B-2610 Antwerp, Belgium
[2] Univ Antwerp, Med Biochem Lab, B-2610 Antwerp, Belgium
[3] Univ Antwerp, Med Chem Lab, B-2610 Antwerp, Belgium
[4] Univ Antwerp, Antwerp Drug Discovery Network, B-2610 Antwerp, Belgium
关键词
Proteases; Proteinase-activated receptors; Protease inhibitors; Visceral hypersensitivity; Visceral pain; Irritable bowel syndrome; Inflammatory bowel diseases; PROTEINASE-ACTIVATED RECEPTOR-2; MAST-CELL TRYPTASE; PHASE-II; NAFAMOSTAT MESILATE; CLINICAL-RELEVANCE; ABDOMINAL-PAIN; RISK-FACTORS; INHIBITOR; HYPERALGESIA; MECHANISMS;
D O I
10.3748/wjg.v22.i47.10275
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Proteases, enzymes catalyzing the hydrolysis of peptide bonds, are present at high concentrations in the gastrointestinal tract. Besides their well-known role in the digestive process, they also function as signaling molecules through the activation of protease-activated receptors (PARs). Based on their chemical mechanism for catalysis, proteases can be classified into several classes: serine, cysteine, aspartic, metallo-and threonine proteases represent the mammalian protease families. In particular, the class of serine proteases will play a significant role in this review. In the last decades, proteases have been suggested to play a key role in the pathogenesis of visceral hypersensitivity, which is a major factor contributing to abdominal pain in patients with inflammatory bowel diseases and/or irritable bowel syndrome. So far, only a few preclinical animal studies have investigated the effect of protease inhibitors specifically on visceral sensitivity while their effect on inflammation is described in more detail. In our accompanying review we describe their effect on gastrointestinal permeability. On account of their promising results in the field of visceral hypersensitivity, further research is warranted. The aim of this review is to give an overview on the concept of visceral hypersensitivity as well as on the physiological and pathophysiological functions of proteases herein.
引用
收藏
页码:10275 / 10286
页数:12
相关论文
共 93 条
[1]
Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents [J].
Akbar, A. ;
Walters, J. R. F. ;
Ghosh, S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (05) :423-435
[2]
Peripheral and central mechanisms of visceral sensitization in man [J].
Anand, P. ;
Aziz, Q. ;
Willert, R. ;
Van Oudenhove, L. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 :29-46
[3]
Epidemiology and risk factors for IBD [J].
Ananthakrishnan, Ashwin N. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (04) :205-217
[4]
Luminal Cysteine-Proteases Degrade Colonic Tight Junction Structure and Are Responsible for Abdominal Pain in Constipation-Predominant IBS [J].
Annahazi, Anita ;
Ferrier, Laurent ;
Bezirard, Valerie ;
Leveque, Mathilde ;
Eutamene, Helene ;
Ait-Belgnaoui, Afifa ;
Coeffier, Moise ;
Ducrotte, Philippe ;
Roka, Richard ;
Inczefi, Orsolya ;
Gecse, Krisztina ;
Rosztoczy, Andras ;
Molnar, Tamas ;
Ringel-Kulka, Tamar ;
Ringel, Yehuda ;
Piche, Thierry ;
Theodorou, Vassilia ;
Wittmann, Tibor ;
Bueno, Lionel .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (08) :1322-1331
[5]
Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice [J].
Annahazi, Anita ;
Gecse, Krisztina ;
Dabek, Marta ;
Ait-Belgnaoui, Afifa ;
Rosztoczy, Andras ;
Roka, Richard ;
Molnar, Tamas ;
Theodorou, Vassilia ;
Wittmann, Tibor ;
Bueno, Lionel ;
Eutamene, Helene .
PAIN, 2009, 144 (1-2) :209-217
[6]
Mechanisms of disease: protease functions in intestinal mucosal pathobiology [J].
Antalis, Toni M. ;
Shea-Donohue, Terez ;
Vogel, Stefanie N. ;
Sears, Cynthia ;
Fasano, Alessio .
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2007, 4 (07) :393-402
[7]
Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial [J].
Armstrong, William B. ;
Taylor, Thomas H. ;
Kennedy, Ann R. ;
Melrose, Raymond J. ;
Messadi, Diana V. ;
Gu, Mai ;
Le, Anh D. ;
Perloff, Marjorie ;
Civantos, Francisco ;
Goodwin, William Jarrard ;
Wirth, Lori J. ;
Kerr, Alexander Ross ;
Meyskens, Frank L., Jr. .
CANCER PREVENTION RESEARCH, 2013, 6 (05) :410-418
[8]
Protease-activated receptor-4 (PAR4): a role as inhibitor of visceral pain and hypersensitivity [J].
Auge, C. ;
Balz-Hara, D. ;
Steinhoff, M. ;
Vergnolle, N. ;
Cenac, N. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (11) :1189-+
[9]
Protective effect of ulinastatin in patients with non-small cell lung cancer after radiation therapy: a randomized, placebo-controlled study [J].
Bao, Pengtao ;
Zhao, Weiguo ;
Li, Yun ;
Liu, Yu ;
Zhou, Yi ;
Liu, Changting .
MEDICAL ONCOLOGY, 2015, 32 (01) :1-8
[10]
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome [J].
Barbara, G ;
Stanghellini, V ;
De Giorgio, R ;
Cremon, C ;
Cottrell, GS ;
Santini, D ;
Pasquinelli, G ;
Morselli-Labate, AM ;
Grady, EF ;
Bunnett, NW ;
Collins, SM ;
Corinalidesi, R .
GASTROENTEROLOGY, 2004, 126 (03) :693-702